Subsequently, MeCP2 is recruited to the methylated ESR1 promoter to ensure its complete repression [78] that infers that distinct protein complexes with opposing transcriptional activities contribute to the epigenetic regulation of ESR1 gene expression in different breast cancer cells. This evidence concerns the gene ESR1 and breast carcinoma.